Angiotensin (1-7) for moderate to severe brain injury
Treatments studied
Part of Brain & nervous system, Injuries & trauma clinical trials.
This study tests a drug called Angiotensin (1-7) to see if it helps people recover from moderate to severe traumatic brain injury. It may reduce damage and improve healing when given shortly after the injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your brain injury must be moderate or severe (low consciousness score and loss of consciousness for at least 30 minutes).
- You must be able to start the study within 48 hours of getting hurt.
- You must be at least 18 years old.
- You cannot have certain other brain conditions like dementia, Parkinson's, or a brain tumor.
- If you are able to become pregnant or father a child, you must agree to use birth control during the study and for 7 days after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational treatment to improve outcomes after a recent non-penetrating traumatic brain injury (like a fall or car crash). It uses early CT/MRI imaging and a blood test soon after injury to see who benefits and how well the treatment works.
This study tests a drug called cyclosporine to see if it can help people with moderate to severe traumatic brain injury. You may be eligible if you have a brain injury seen on CT and can start treatment within 24 hours.
This trial tests giving a simple salt solution (sodium lactate) to people with severe traumatic brain injury. The goal is to see if it can reduce swelling and improve recovery.
This study is looking at people with traumatic brain injuries to improve how they are treated. If you join, you will get an MRI and other tests within the first two days after your injury, and the researchers will track your recovery over time.
This study looks at patients with severe traumatic brain injury (TBI) who already need brain pressure or oxygen monitoring. Doctors want to see if certain tests can help predict how well someone might recover.
This trial tests whether taking an anti–blood clot medicine (dalteparin) and using leg compression can reduce dangerous blood clots after a severe traumatic brain injury. It may help lower the chance of clots forming when people are immobile and at higher risk.
Hear when a new Traumatic Brain Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.